Months after it first went for a formal US listing, Relief Therapeutics is withdrawing its IPO application in what the rare disease player calls a change of plans.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,